STAT News

STAT+: Definium Therapeutics says its LSD therapy eased anxiety in late-stage trial

Definium Therapeutics said that its LSD therapy significantly helped patients with generalized anxiety disorder in the first of two large trials.

Por STAT News

1 minuto de lectura
Compartir
STAT+: Definium Therapeutics says its LSD therapy eased anxiety in late-stage trial
STAT+: Definium Therapeutics says its LSD therapy eased anxiety in late-stage trial

¿Tiene noticias que compartir con el sector de eventos?

Envíe un comunicado de prensa o una noticia y llegue a miles de profesionales del sector de eventos.

Contáctenos→

Más en Health Tech

Perspectivas relacionadas